3.3 Neuroinflammation Neuroinflammation has emerged as a central and biologically plausible contributor to the pathophysiology of depressive disorders, bridging immune dysregulation with alterations in neurotransmission, neuroplasticity, and stress responsivity (30, 31)
Because of potential side effects and concerns about cartilage development, pediatric use is limited to cases of serious infections in which the benefits outweigh the risks
Heart palpitations are not listed as a common adverse effect in the FDA-approved prescribing information for tirzepatide, and there is no established direct causal link between tirzepatide use and palpitations in the pivotal clinical trial data
c2019 [cited 2019 Sep 9].Available from: International Agency for Research on Cancer
Suryadevara V, Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, et al